Table of Contents

2019-2024 Global Viral Vector Vaccines Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Viral Vector Vaccines Consumption 2014-2024
  • 2.1.2 Viral Vector Vaccines Consumption CAGR by Region
• 2.2 Viral Vector Vaccines Segment by Type
  • 2.2.1 Adenovirus
  • 2.2.2 Fowlpox Virus
  • 2.2.3 Attenuated Yellow Fever
  • 2.2.4 Vaccinia Virus Vectors
  • 2.2.5 Others
• 2.3 Viral Vector Vaccines Consumption by Type
  • 2.3.1 Global Viral Vector Vaccines Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Viral Vector Vaccines Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Viral Vector Vaccines Sale Price by Type (2014-2019)
• 2.4 Viral Vector Vaccines Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Clinics
  • 2.4.3 Others
• 2.5 Viral Vector Vaccines Consumption by Application
  • 2.5.1 Global Viral Vector Vaccines Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Viral Vector Vaccines Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Viral Vector Vaccines Sale Price by Application (2014-2019)

3 Global Viral Vector Vaccines by Players

• 3.1 Global Viral Vector Vaccines Sales Market Share by Players
  • 3.1.1 Global Viral Vector Vaccines Sales by Players (2017-2019)
  • 3.1.2 Global Viral Vector Vaccines Sales Market Share by Players (2017-2019)
• 3.2 Global Viral Vector Vaccines Revenue Market Share by Players
  • 3.2.1 Global Viral Vector Vaccines Revenue by Players (2017-2019)
  • 3.2.2 Global Viral Vector Vaccines Revenue Market Share by Players (2017-2019)
• 3.3 Global Viral Vector Vaccines Sale Price by Players
• 3.4 Global Viral Vector Vaccines Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Viral Vector Vaccines Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Viral Vector Vaccines Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Viral Vector Vaccines by Regions

• 4.1 Viral Vector Vaccines by Regions
  • 4.1.1 Global Viral Vector Vaccines Consumption by Regions
  • 4.1.2 Global Viral Vector Vaccines Value by Regions
• 4.2 Americas Viral Vector Vaccines Consumption Growth
• 4.3 APAC Viral Vector Vaccines Consumption Growth
• 4.4 Europe Viral Vector Vaccines Consumption Growth
• 4.5 Middle East & Africa Viral Vector Vaccines Consumption Growth

5 Americas

• 5.1 Americas Viral Vector Vaccines Consumption by Countries
  • 5.1.1 Americas Viral Vector Vaccines Consumption by Countries (2014-2019)
  • 5.1.2 Americas Viral Vector Vaccines Value by Countries (2014-2019)
• 5.2 Americas Viral Vector Vaccines Consumption by Type
• 5.3 Americas Viral Vector Vaccines Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Viral Vector Vaccines Consumption by Countries
  • 6.1.1 APAC Viral Vector Vaccines Consumption by Countries (2014-2019)
  • 6.1.2 APAC Viral Vector Vaccines Value by Countries (2014-2019)
• 6.2 APAC Viral Vector Vaccines Consumption by Type
• 6.3 APAC Viral Vector Vaccines Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Viral Vector Vaccines by Countries
  • 7.1.1 Europe Viral Vector Vaccines Consumption by Countries (2014-2019)
  • 7.1.2 Europe Viral Vector Vaccines Value by Countries (2014-2019)
• 7.2 Europe Viral Vector Vaccines Consumption by Type
• 7.3 Europe Viral Vector Vaccines Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Viral Vector Vaccines by Countries
  • 8.1.1 Middle East & Africa Viral Vector Vaccines Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Viral Vector Vaccines Value by Countries (2014-2019)
• 8.2 Middle East & Africa Viral Vector Vaccines Consumption by Type
• 8.3 Middle East & Africa Viral Vector Vaccines Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Viral Vector Vaccines Distributors
• 10.3 Viral Vector Vaccines Customer

11 Global Viral Vector Vaccines Market Forecast

• 11.1 Global Viral Vector Vaccines Consumption Forecast (2019-2024)
• 11.2 Global Viral Vector Vaccines Forecast by Regions
  • 11.2.1 Global Viral Vector Vaccines Forecast by Regions (2019-2024)
  • 11.2.2 Global Viral Vector Vaccines Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Viral Vector Vaccines Forecast by Type
• 11.8 Global Viral Vector Vaccines Forecast by Application

12 Key Players Analysis

• 12.1 Advanced Bioscience Laboratories
  • 12.1.1 Company Details
  • 12.1.2 Viral Vector Vaccines Product Offered
  • 12.1.3 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Advanced Bioscience Laboratories News
• 12.2 Boehringer Ingelheim
  • 12.2.1 Company Details
  • 12.2.2 Viral Vector Vaccines Product Offered
  • 12.2.3 Boehringer Ingelheim Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Boehringer Ingelheim News
• 12.3 Brammer Bio
  • 12.3.1 Company Details
  • 12.3.2 Viral Vector Vaccines Product Offered
  • 12.3.3 Brammer Bio Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Brammer Bio News
• 12.4 Creative Biogene
  • 12.4.1 Company Details
  • 12.4.2 Viral Vector Vaccines Product Offered
  • 12.4.3 Creative Biogene Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Creative Biogene News
• 12.5 GE Healthcare
  • 12.5.1 Company Details
  • 12.5.2 Viral Vector Vaccines Product Offered
  • 12.5.3 GE Healthcare Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 GE Healthcare News
• 12.6 Pfizer
  • 12.6.1 Company Details
  • 12.6.2 Viral Vector Vaccines Product Offered
  • 12.6.3 Pfizer Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Pfizer News
• 12.7 Sanofi
  • 12.7.1 Company Details
  • 12.7.2 Viral Vector Vaccines Product Offered
  • 12.7.3 Sanofi Viral Vector Vaccines Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Sanofi News

...

13 Research Findings and Conclusion

Viral vector vaccines combine many of the positive qualities of DNA vaccines with those of live attenuated vaccines.

According to this study, over the next five years the Viral Vector Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Viral Vector Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Viral Vector Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Viral Vector Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Advanced Bioscience Laboratories
Boehringer Ingelheim
Brammer Bio
Creative Biogene
GE Healthcare
Pfizer
Sanofi
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Viral Vector Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Viral Vector Vaccines market by identifying its various subsegments.
Focuses on the key global Viral Vector Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Viral Vector Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Viral Vector Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.